W. Torre

发表

Early lung cancer detection using spiral computed tomography and positron emission tomography.

G. Bastarrika, L. Montuenga, M. Lozano, 2005, American journal of respiratory and critical care medicine.

[Validation of segmentation techniques for positron emission tomography using ex-vivo images of oncological surgical specimens].

J. Martí-Climent, E. Prieto, J. Alcázar, 2014 .

Long-term results after resection for bone sarcoma pulmonary metastases.

S. Martín-Algarra, F. Guillén-Grima, M. San-Julián, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18F]-FDG PET and Localized Fibrous Mesothelioma

J. Castellano, J. Cortés, M. J. García-Velloso, 2003, Lung.

[Value of Pet-18FDG in lung cancer].

A. Brugarolas, J. Richter, C. Gamez, 1999, Medicina clinica.

Molecular Profiling of Computed Tomography Screen-Detected Lung Nodules Shows Multiple Malignant Features

Gorka Bastarrika, Jackeline Agorreta, Luis M. Montuenga, 2006, Cancer Epidemiology Biomarkers & Prevention.

The Oncoprotein SF2/ASF Promotes Non–Small Cell Lung Cancer Survival by Enhancing Survivin Expression

M. Pajares, L. Montuenga, R. Pio, 2010, Clinical Cancer Research.

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

M. Esteller, D. Beer, Guoan Chen, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary Mixed Squamous Carcinoma and Osteosarcoma (Carcinosarcomas) of the Lung Have a CGH Mapping Similar to Primitive Squamous Carcinomas and Osteosarcomas

E. Álava, J. García, A. Panizo, 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

S. Vicent, J. Soria, L. Montuenga, 2004, British Journal of Cancer.

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

I. Wistuba, E. Felip, C. Behrens, 2018, Thorax.

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

P. Massion, M. Pajares, J. de-Torres, 2013, Journal of the National Cancer Institute.

Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).

M. Pajares, J. de-Torres, G. Bastarrika, 2015, Archivos de bronconeumologia.

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.

I. Wistuba, E. Brambilla, C. Behrens, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Cancer esearch an Cancer Biology Oncoprotein SF 2 / ASF Promotes Non – Small Cell Lung R cer Survival by Enhancing Survivin Expression

M. Pajares, L. Montuenga, R. Pio, 2010 .

Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer.

S. Vicent, J. García-Foncillas, L. Montuenga, 2003, Lung cancer.

Features Screen-Detected Lung Nodules Shows Multiple Malignant Molecular Profiling of Computed Tomography

G. Bastarrika, L. Montuenga, R. Pio, 2006 .

Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.

J. de-Torres, G. Bastarrika, J. Zulueta, 2016, Lung cancer.